Key facts
- Machine Medicine Technologies’s last known valuation is $16.9M (Aug 2022).
- It has raised $4.8M; the latest was Later Stage VC in Apr 2025.
- Notable investors include Innovate UK, SOSV, Entrepreneurs First, Village Capital, Matter (Consulting Services (B2B)) — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Machine Medicine Technologies
- ·The full record, as it builds
Funding rounds
No funding rounds for Machine Medicine Technologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Machine Medicine Technologies
Developer of a healthcare platform designed to digitally detect the motor characteristics of Parkinson's disease. The company's platform uses computer vision technology and artificial intelligence algorithms to objectively track the movement of the patients down to the fingertip level and deliver objective metrics of core symptoms such as tremors and bradykinesia, enabling researchers to record, score, and analyze video of Parkinson's patients during the motor assessment.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2017
- Employees
- 17
- Website
- machinemedicine.io/
- Ownership
- Privately Held (backing)
Machine Medicine Technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Machine Medicine Technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Machine Medicine Technologies in its N-PORT filings yet. We sweep new filings monthly.